Compare Mutual Funds
Pros | Among most bought funds within the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 8/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 6 Months | 13 Years 6 Months | ||
Fund AUM | ₹2892 Cr | ₹7898 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.62% | 0.93% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 33 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.55% | 99.46% | ||
Debt % | - | - | ||
P/E | 31.94 | 34.36 | ||
P/B | 4.35 | 5.45 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 9.76% | 10.04% | ||
3-Month Return | 6.89% | 7.93% | ||
6-Month Return | 0.92% | 4.43% | ||
1-Year Return | 7.6% | 9.49% | ||
3-Year Return | 23.91% | 24.71% | ||
5-Year Return | 15.21% | 14.55% |
Sharpe | 1.04 | 1.01 | ||
Alpha | 0.8 | -0.24 | ||
Beta | 0.86 | 0.91 | ||
Standard Deviation | 15.49 | 15.78 | ||
Information Ratio | -0.32 | -0.55 |
Description | DSP Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Chirag Dagli | Sailesh Raj Bhan, Amber Singhania, Kinjal Desai |

